000 | 01130 a2200313 4500 | ||
---|---|---|---|
005 | 20250511175257.0 | ||
264 | 0 | _c19930408 | |
008 | 199304s 0 0 eng d | ||
022 | _a0300-8177 | ||
024 | 7 |
_a10.1007/BF00299389 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeglicki, W B | |
245 | 0 | 0 |
_aAntioxidant drug mechanisms: transition metal-binding and vasodilation. _h[electronic resource] |
260 |
_bMolecular and cellular biochemistry _cDec 1992 |
||
300 |
_a105-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aCaptopril _xchemistry |
650 | 0 | 4 |
_aHydrazines _xchemistry |
650 | 0 | 4 |
_aMetals _xmetabolism |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aPyridines _xchemistry |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
700 | 1 | _aMak, I T | |
773 | 0 |
_tMolecular and cellular biochemistry _gvol. 118 _gno. 2 _gp. 105-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00299389 _zAvailable from publisher's website |
999 |
_c1300032 _d1300032 |